This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Celliver Biotechnology Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Xiaofang Jin in Tumor Tissue Preservation
Introduction
Xiaofang Jin is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the preservation of tumor tissues. His innovative work has the potential to enhance cancer research and treatment methodologies.
Latest Patents
Xiaofang Jin holds a patent for a tumor tissue cryopreservation kit, tumor tissue resuscitation kit, and method of cryopreserving and/or resuscitating tumor tissue. This patent includes a comprehensive kit that consists of a first solution and a second solution, along with a metal mesh. The first solution comprises dulbecco's modified eagle medium (DMEM), dimethyl sulfoxide (DMSO), ethylene glycol (EG), bovine serum albumin (BSA), sucrose, methylcellulose, hetastarch, and glucose. The second solution also contains DMEM, DMSO, EG, BSA, sucrose, methylcellulose, polyvinyl pyrrolidone (PVP), and glucose. The metal mesh is designed with a thickness of 0.15-0.2 mm and features square holes that facilitate the preservation process.
Career Highlights
Xiaofang Jin is currently associated with Shanghai Celliver Biotechnology Inc., where he continues to innovate in the field of biotechnology. His work is pivotal in advancing techniques for tumor tissue preservation, which is crucial for cancer research and treatment.
Collaborations
Xiaofang collaborates with talented individuals such as Min Zeng and Xu Zhou, who contribute to the research and development efforts at Shanghai Celliver Biotechnology Inc. Their combined expertise enhances the potential for groundbreaking advancements in biotechnology.
Conclusion
Xiaofang Jin's contributions to tumor tissue preservation through his innovative patent demonstrate his commitment to advancing cancer research. His work at Shanghai Celliver Biotechnology Inc. positions him as a key figure in the biotechnology industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile